EquiCoxib™ (firocoxib) Oral Solution for Horses

EquiCoxib™ the first FDA-Approved oral solution of firocoxib designed to help more accurately dose horses regardless of weight compared to the wide dosing range specified in dosing firocoxib tables, in treating pain and inflammation associated with osteoarthritis in horses.

Product Features

Proven pharmacokinetic, bioequivalence to Equioxx® Paste in a blinded, controlled cross-over study
Accurate dosing based on the actual weight of the horse
Newly designed draw-off-cap and syringe for easier, economical dispensing
Flavorless oral solution horses readily consume

Package presentation	Available
90mL	Reorder No: 28008
400mL	Reorder No: 28009

Clicking a link on this page will open a PDF file in a new window.

IMPORTANT SAFETY INFORMATION:
For oral use in horses only. Do not inject EquiCoxib™. Do not use in horses intended for human consumption. EquiCoxib™ is contraindicated in horses with a hypersensitivity to firocoxib. As with any prescription medication, prior to use, a veterinarian should perform a physical examination and review the horse’s medical history. Treatment with EquiCoxib™ should be terminated if signs such as inappetance, colic, abnormal feces, or lethargy are observed. As a class, nonsteroidal anti-inflammatory drugs may be associated with gastrointestinal, hepatic and renal toxicity. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. EquiCoxib™ has not been tested in horses less than 1 year of age or in breeding horses, or pregnant or lactating mares. Keep out of the reach of children. For complete safety information, refer to the package insert.